Skip to main content
Log in

Anthracyclines/trastuzumab

Cardiotoxicity: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Sasaki R, et al. ESTABLISHMENT OF IN VITRO EXPERIMNTAL MODEL SYSTEMS OF PATIENT-DERIVED IPSCS CARDIOMYOCYTE FOR EVALUATION OF TRASTUZUMAB-INDUCED SEVERE CARDIOTOXICITY. Supportive Care in Cancer 30 (Suppl. 1): S117-S118 abstr. 07, Jun 2022. Available from: URL: https://link.springer.com/content/pdf/10.1007/s00520-022-07099-y.pdf [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anthracyclines/trastuzumab. Reactions Weekly 1918, 44 (2022). https://doi.org/10.1007/s40278-022-20501-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-20501-z

Navigation